Welcure Drugs & Pharmaceuticals Ltd — Quarterly Results & Earnings

₹0.24

-3.85%

Profit Growth YoY361.96%Latest quarter

Sales Growth YoY167.29%Latest quarter

Sales CAGR 5Y214.33%5 year compound

Profit CAGR 5Y193.83%5 year compound

📋

Quarterly Performance

YoY Profit Growth+361.96%

🔥 Exceptional growth

YoY Sales Growth+167.29%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

94.95%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

4.18%

ROCE

2.53%

💡

Growth Analysis

Welcure Drugs & Pharmaceuticals Ltd reported YoY profit growth of 361.96% and revenue growth of 167.29% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 214.33% and profits at 193.83% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Welcure Drugs & Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.